Jinkai Biotech Co., Ltd.
金凯生科
301509
Shenzhen Stock Exchange
Key Financials
Announcements
Announcement on the Implementation of 2025 Annual Equity Distribution
Announcement on Pre-Disclosure of Shareholder Share Reduction
Legal Opinion on the 2025 Shareholders' Meeting of Jinkai (Liaoning) Life Science Co., Ltd. by Zhonglun Law Firm (Beijing)
Announcement of Shareholders' Meeting Resolutions for 2025
Tracking Report from CITIC Jinshi Securities Co., Ltd. on Jinkai (Liaoning) Life Science Co., Ltd. for 2025
Verification opinion from CITIC Securities Co., Ltd. on the extension of certain raised fund investment projects by Jinkai (Liaoning) Life Science Technology Co., Ltd.
Special verification report from CITIC Securities Co., Ltd. on the storage, management, and use of raised funds by Jinkai (Liaoning) Life Science Technology Co., Ltd. for the year 2025
Announcement on the reappointment of the company's auditing institution for the year 2026
Announcement on the compensation plan for directors and senior management for the year 2026
Board of directors' work report for the year 2025
Independent director work report for the year 2025 (Liu Yuanyuan)
Independent director work report for the year 2025 (You Song)
Independent director work report for the year 2025 (Guo Yukun)
Announcement on holding an online performance briefing for the year 2025
Verification opinion from CITIC Securities Co., Ltd. on the internal control evaluation report of Jinkai (Liaoning) Life Science Technology Co., Ltd. for the year 2025
Internal control audit report of Jinkai (Liaoning) Life Science Technology Co., Ltd.
Internal control evaluation report for the year 2025
Internal control management system (April 2026)
Director and senior management compensation management system (revised in April 2026)
Financial management system (revised in April 2026)
Company's shareholder dividend return plan for the next three years (2026-2028)
Announcement on the provision for asset impairment for the year 2025
Announcement on the extension of certain raised fund investment projects
Notice of the 2025 annual shareholders' meeting
Resolution announcement of the 11th meeting of the second board of directors
Announcement on the profit distribution plan for the year 2025
First quarter report for 2026
Special report on the storage, management, and use of raised funds for the year 2025
Verification report on the storage, management, and use of raised funds by Jinkai (Liaoning) Life Science Technology Co., Ltd.
Evaluation report on the performance of the accounting firm for the year 2025 and the report on the fulfillment of supervisory responsibilities by the audit committee of the board of directors
Special explanation on non-operating fund occupation and other related fund transactions by Jinkai (Liaoning) Life Science Technology Co., Ltd.
Summary table of non-operating fund occupation and other related fund transactions for the year 2025
Special report on the self-examination of the independence of independent directors for the year 2025 by the board of directors
2025 Annual Audit Report
2025 Annual Report
Summary of the 2025 annual report
CITIC Securities Co., Ltd. Regarding the 'Shenzhen Stock Exchange Listed Company Regular On-site Inspection Report'
Announcement on the Expiration of the Share Reduction Plan Period and Reduction Results by Shareholders
Notes & Comments
Sign in to leave a comment or private note.
Loading…